NEW YORK, Nov. 1 – A recent $12 million private equity infusion has spurred Protedyne to expand its manufacturing operations and hire on 30 new staff, the company said on Thursday.

Protedyne, based in Windsor, Conn., said that the capital also will be used to help the research-automation firm bolster its new BioCube and BioResearch products.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.